| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $1.99 | $2.15 | $2.45 | $1.48 | $1.46 | $0.42 | $0.51 | $0.57 |
| EPS (Diluted) | $1.99 | $2.15 | $2.45 | $1.47 | $1.45 | $0.41 | $0.50 | $0.56 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.8B | $10.9B | $10.6B | $10.9B | $4.5B | $3.9B | $3.5B | $3.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.9B | $0.4B | $0.4B | — | — | — | — |
| Total Liabilities | $9.1B | $9.3B | $9.1B | $9.5B | $3.9B | $3.4B | $2.9B | $2.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.7B | $1.6B | $1.5B | $1.4B | $0.6B | $0.5B | $0.5B | $0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.2B | $0.1B | $0.0B | $0.0B | $0.1B | $0.0B |
| Investing Cash Flow | $-0.3B | $0.2B | $0.3B | $0.1B | $-0.1B | $-0.3B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | — | — | — | — |
| Financing Cash Flow | $-0.2B | $0.1B | $-0.4B | $-0.6B | $0.5B | $0.4B | $0.1B | $0.2B |